Loading insider details...
Beta
Latest Form 4 (Sep 1, 2026): Disposition to Issuer of 116,146 CRNX shares, $9.87M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 1, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Disposition to Issuer | 116,146 | $9.87M |
| Jul 16, 2026 | CYTOKINETICS INC (CYTK) | Grant/Award | 75 | $6.2K |
| Jun 22, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/Award | 5,925 | n/a |
| May 27, 2026 | CYTOKINETICS INC (CYTK) | Grant/Award | 2,851 | n/a |
| May 5, 2026 | CYTOKINETICS INC (CYTK) | Exercise/Conversion | 4,032 | $50.0K |
| Apr 15, 2026 | CYTOKINETICS INC (CYTK) | Grant/Award | 95 | $6.2K |
| Jan 16, 2026 | CYTOKINETICS INC (CYTK) | Grant/Award | 98 | $6.2K |
| Jan 7, 2026 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 2,500 | n/a |
| Dec 23, 2025 | CYTOKINETICS INC (CYTK) | Exercise/Conversion | 20,000 | $152.2K |
| Oct 27, 2025 | CYTOKINETICS INC (CYTK) | Exercise/Conversion | 4,375 | $43.8K |